Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Vifor Pharma Nordiska AB

Closing information (x1000 SEK)

Closing information 2023/06 2021/12 2020/12
Turnover 243,890 Less Arrow 225,847
Financial expenses 738 Less Arrow 99
Earnings before taxes 7,164 Less Arrow 5,733
EBITDA 8,094 Less Arrow 6,058
Total assets 264,550 Less Arrow 219,154
Current assets 263,992 Less Arrow 218,393
Current liabilities 108,582 More Arrow 177,211
Equity capital 40,968 Less Arrow 35,843
- share capital 200 Equal arrow 200
Employees (average) 46 Less Arrow 40 Less Arrow 38

Financial ratios

Fiscal year 2023/06 2021/12 2020/12
Solvency 15.5% More Arrow 16.4%
Turnover per employee 6,097 Less Arrow 5,943
Profit as a percentage of turnover 2.9% Less Arrow 2.5%
Return on assets (ROA) 3.0% Less Arrow 2.7%
Current ratio 243.1% Less Arrow 123.2%
Return on equity (ROE) 17.5% Less Arrow 16.0%
Change turnover 18,043 Less Arrow 11,039
Change turnover % 78% Less Arrow 8% Less Arrow 5%
Chg. No. of employees 6 Less Arrow 2 More Arrow 3
Chg. No. of employees % 15% Less Arrow 5% More Arrow 9%

Total value of public sale

Fiscal year 2023/06 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.